Dolby Laboratories, Inc.: other noncurrent liabilities
Other noncurrent liabilities for Dolby Laboratories, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Dolby Laboratories, Inc. financial histories
What this measure means
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
Exact concept: us-gaap:OtherLiabilitiesNoncurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2009-09-25 to 2025-09-26. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-09-26 | 99,843,000 | USD | 2025-11-18 | 10-K · 0001308547-25-000007 |
| At date | 2024-09-27 | 135,852,000 | USD | 2025-11-18 | 10-K · 0001308547-25-000007 |
| At date | 2023-09-29 | 108,339,000 | USD | 2024-11-19 | 10-K · 0001628280-24-048519 |
| At date | 2022-09-30 | 100,122,000 | USD | 2023-11-17 | 10-K · 0001628280-23-039389 |
| At date | 2021-09-24 | 105,310,000 | USD | 2022-11-18 | 10-K · 0001628280-22-030390 |
| At date | 2020-09-25 | 122,154,000 | USD | 2021-11-17 | 10-K · 0001628280-21-023630 |
| At date | 2019-09-27 | 177,462,000 | USD | 2020-11-16 | 10-K · 0001628280-20-016459 |
| At date | 2018-09-28 | 183,799,000 | USD | 2019-11-25 | 10-K · 0001628280-19-014472 |
| At date | 2017-09-29 | 107,514,000 | USD | 2018-11-15 | 10-K · 0001628280-18-014390 |
| At date | 2016-09-30 | 82,922,000 | USD | 2017-11-16 | 10-K · 0001628280-17-011633 |
| At date | 2015-09-25 | 77,024,000 | USD | 2016-11-18 | 10-K · 0001628280-16-021559 |
| At date | 2014-09-26 | 43,715,000 | USD | 2015-11-24 | 10-K · 0001628280-15-008974 |
| At date | 2013-09-27 | 45,441,000 | USD | 2014-11-18 | 10-K · 0001445305-14-005158 |
| At date | 2012-09-28 | 39,837,000 | USD | 2013-11-15 | 10-K · 0001308547-13-000011 |
| At date | 2011-09-30 | 23,455,000 | USD | 2012-11-15 | 10-K · 0001308547-12-000010 |
| At date | 2010-09-24 | 27,015,000 | USD | 2011-11-23 | 10-K · 0001193125-11-320293 |
| At date | 2009-09-25 | 31,469,000 | USD | 2010-11-22 | 10-K · 0001193125-10-266157 |
Related financial histories
- Dolby Laboratories, Inc.: total assets
- Dolby Laboratories, Inc.: total liabilities
- Dolby Laboratories, Inc.: stockholders equity
- Dolby Laboratories, Inc.: cash and cash equivalents
- Dolby Laboratories, Inc.: net income or loss
- Dolby Laboratories, Inc.: operating cash flow
- Dolby Laboratories, Inc.: capital expenditure payments
- Dolby Laboratories, Inc.: revenue
- Dolby Laboratories, Inc.: contract revenue excluding tax
- Dolby Laboratories, Inc.: financing cash flow
- Dolby Laboratories, Inc.: investing cash flow
- Dolby Laboratories, Inc.: retained earnings or deficit
- Dolby Laboratories, Inc.: basic weighted-average shares
- Dolby Laboratories, Inc.: diluted weighted-average shares
- Dolby Laboratories, Inc.: basic earnings per share
- Dolby Laboratories, Inc.: diluted earnings per share
- Dolby Laboratories, Inc.: income tax expense or benefit
- Dolby Laboratories, Inc.: net property, plant and equipment
- Dolby Laboratories, Inc.: share-based compensation expense
- Dolby Laboratories, Inc.: operating income or loss
- Dolby Laboratories, Inc.: current assets
- Dolby Laboratories, Inc.: interest expense
- Dolby Laboratories, Inc.: current liabilities
- Dolby Laboratories, Inc.: current accounts payable
- Dolby Laboratories, Inc.: goodwill carrying amount
- Dolby Laboratories, Inc.: net finite-lived intangible assets
- Dolby Laboratories, Inc.: net current accounts receivable
- Dolby Laboratories, Inc.: common-stock repurchase payments
- Dolby Laboratories, Inc.: operating expenses
- Dolby Laboratories, Inc.: net inventory
- Dolby Laboratories, Inc.: gross profit
- Dolby Laboratories, Inc.: cost of revenue
- Dolby Laboratories, Inc.: research and development expense
- Dolby Laboratories, Inc.: cash including restricted cash
- Dolby Laboratories, Inc.: accumulated other comprehensive income or loss
- Dolby Laboratories, Inc.: total equity including noncontrolling interests
- Dolby Laboratories, Inc.: operating lease right-of-use asset
- Dolby Laboratories, Inc.: operating lease liability
- Dolby Laboratories, Inc.: gross property, plant and equipment
- Dolby Laboratories, Inc.: accumulated depreciation on property, plant and equipment
- Dolby Laboratories, Inc.: net intangible assets excluding goodwill
- Dolby Laboratories, Inc.: other noncurrent assets
- Dolby Laboratories, Inc.: accrued current liabilities
- Dolby Laboratories, Inc.: prepaid expenses and other current assets
- Dolby Laboratories, Inc.: current contract liabilities
- Dolby Laboratories, Inc.: net deferred tax assets
- Dolby Laboratories, Inc.: pre-tax income or loss from continuing operations
- Dolby Laboratories, Inc.: profit or loss including noncontrolling interests
- Dolby Laboratories, Inc.: comprehensive income or loss
- Dolby Laboratories, Inc.: general and administrative expense
- Dolby Laboratories, Inc.: depreciation expense
- Dolby Laboratories, Inc.: amortization of intangible assets
- Dolby Laboratories, Inc.: other nonoperating income or expense
- Dolby Laboratories, Inc.: nonoperating income or expense
- Dolby Laboratories, Inc.: current income tax expense or benefit
- Dolby Laboratories, Inc.: deferred income tax expense or benefit
- Dolby Laboratories, Inc.: operating lease payments
- Dolby Laboratories, Inc.: change in accounts receivable
- Dolby Laboratories, Inc.: change in inventories
Inspect the source
- Entity
- Dolby Laboratories, Inc. / CIK 0001308547
- Captured
- 2026-09-20T07:51:10.545Z
- SEC response SHA-256
cc65a6f34013f443da51e389f537bca7ca8bca8cc3e2da20106c70e8530cc05b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001308547.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))